Table 1.
Treatment | Exudate volume (mL) | Inflammatory cells × 106 | PGE2 (ng·rat−1) |
---|---|---|---|
Vehicle | 0.19 ± 0.020 | 47.1 ± 3.0 | 2.15 ± 0.20 |
β-BA | 0.029 ± 0.016*** | 29.6 ± 2.8*** | 1.21 ± 0.14** |
1 mg·kg−1 | 85% | 37% | 44% |
Indo | 0 | 17.0 ± 4.9** | n.d. |
5 mg·kg−1 | 100% | 64% | 100% |
P < 0.01;
P < 0.001 versus vehicle.
Thirty minutes before intrapleural injection of carrageenan, rats (n = 11 for each experimental group) were treated per os with 1 mg·kg−1β-BA, 5 mg·kg−1 indomethacin (indo) or vehicle (water containing 0.5% CMC, 10% Tween-20 and 1% sesame oil). Exudate volume and PGE2, as well as inflammatory cell accumulation in the pleural cavity were assessed 4 h after carrageenan injection. Data are expressed as mean ± SEM, n = 11.
β-BA, β-boswellic acid; n.d., not detectable, under the limit of detection of the assay (0.0625 ng·mL−1).